Earth Science Tech (OTCQB: ETST), a strategic holding company in the healthcare, pharmacy, and telemedicine sector, has successfully uplisted to the OTCQB Venture Market, effective September 17, 2026. The OTCQB is an established public market for growth-stage and entrepreneurial companies, and the listing means ETST has met rigorous financial and reporting standards, undergone a verification process, and complied with strict management certification requirements. The uplisting is the latest in a series of milestones for the company in fiscal year 2027, which began on April 1, 2026.
During the current fiscal year, Earth Science Tech reported its Q1 2027 financial results, which showed a 3% growth in revenue and a 57% increase in net income. The company also acquired Meduvo LLC, a compounding pharmacy, and Zoolzy LLC, and held its annual meeting of shareholders. These developments, combined with the uplisting, position the company for greater visibility and credibility in the public markets.
The move to OTCQB is significant because it provides investors with a trusted trading environment that requires higher levels of disclosure and transparency than the OTC Pink market. For a growth-stage company like Earth Science Tech, this can enhance liquidity, attract a broader investor base, and improve access to capital. The company’s newsroom, available at https://ibn.fm/ETST, offers the latest news and updates relating to ETST.
The announcement was distributed by InvestorWire, a specialized communications platform focused on advanced wire-grade press release syndication. InvestorWire is one of more than 75 brands within the Dynamic Brand Portfolio at IBN, which delivers a range of services including article and editorial syndication to 5,000+ outlets, press release enhancement, social media distribution, and corporate communications solutions. For more information, visit InvestorWire at https://www.InvestorWire.com. Full terms of use and disclaimers are available at https://www.InvestorWire.com/Disclaimer.
For investors, the uplisting to OTCQB is a critical step because it signals that Earth Science Tech has satisfied stringent compliance and reporting obligations, which can reduce risk and increase confidence. The combination of revenue growth, strategic acquisitions, and a shareholder meeting underscores the company’s efforts to build value. As a holding company in the healthcare, pharmacy, and telemedicine sector, Earth Science Tech operates in industries that are increasingly reliant on technology and accessible care. The uplisting may help the company gain recognition among a wider pool of investors and partners.
The broader context of this news is that small-cap companies often struggle to gain visibility and credibility. By meeting OTCQB standards, Earth Science Tech distinguishes itself from companies on lower-tier markets. The fiscal 2027 milestones, including the financial performance and acquisitions, suggest a trajectory of growth. However, investors should note that the company remains subject to the risks inherent in its sector and the public markets. The full details of the uplisting and other milestones are available through the company’s newsroom at https://ibn.fm/0TQ91 and via the Earth Science Tech (OTCQB: ETST) client page.
